| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 5 | 2018 | 150 | 1.230 |
Why?
|
| Reactive Oxygen Species | 5 | 2018 | 517 | 1.120 |
Why?
|
| Histone Demethylases | 5 | 2018 | 34 | 1.040 |
Why?
|
| Hepatocyte Growth Factor | 5 | 2014 | 86 | 0.670 |
Why?
|
| Erythrocytes | 2 | 2018 | 254 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-met | 9 | 2009 | 201 | 0.610 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.550 |
Why?
|
| Hemoglobin, Sickle | 1 | 2017 | 17 | 0.550 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 217 | 0.460 |
Why?
|
| Fetal Hemoglobin | 4 | 2018 | 14 | 0.420 |
Why?
|
| Mitochondria | 1 | 2017 | 623 | 0.390 |
Why?
|
| Enzyme Inhibitors | 4 | 2018 | 657 | 0.350 |
Why?
|
| Lung Neoplasms | 7 | 2008 | 2463 | 0.330 |
Why?
|
| Intestinal Mucosa | 5 | 2015 | 825 | 0.310 |
Why?
|
| gamma-Globins | 3 | 2018 | 5 | 0.290 |
Why?
|
| Indoles | 6 | 2009 | 317 | 0.290 |
Why?
|
| Paxillin | 2 | 2008 | 59 | 0.290 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 159 | 0.250 |
Why?
|
| Piperazines | 5 | 2009 | 296 | 0.230 |
Why?
|
| Sulfonamides | 5 | 2009 | 338 | 0.220 |
Why?
|
| Pleural Neoplasms | 1 | 2006 | 205 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2007 | 1172 | 0.200 |
Why?
|
| Mesothelioma | 1 | 2006 | 333 | 0.190 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2014 | 82 | 0.180 |
Why?
|
| Reticulocytes | 3 | 2018 | 25 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 349 | 0.180 |
Why?
|
| Disease Models, Animal | 6 | 2018 | 2551 | 0.170 |
Why?
|
| Quercetin | 1 | 2000 | 3 | 0.170 |
Why?
|
| Carotenoids | 1 | 2000 | 17 | 0.160 |
Why?
|
| Rhabdomyosarcoma | 1 | 2000 | 44 | 0.160 |
Why?
|
| Animals | 18 | 2018 | 28945 | 0.160 |
Why?
|
| Anticarcinogenic Agents | 1 | 2000 | 71 | 0.160 |
Why?
|
| RNA, Small Interfering | 6 | 2009 | 567 | 0.160 |
Why?
|
| Mice | 10 | 2018 | 12562 | 0.150 |
Why?
|
| Receptors, Growth Factor | 2 | 2009 | 52 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2011 | 2794 | 0.150 |
Why?
|
| Tretinoin | 2 | 2015 | 131 | 0.140 |
Why?
|
| Hemolysis | 1 | 2017 | 63 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2012 | 684 | 0.130 |
Why?
|
| Rhodamines | 1 | 2017 | 20 | 0.130 |
Why?
|
| Spiro Compounds | 1 | 2017 | 30 | 0.130 |
Why?
|
| Papio | 4 | 2018 | 87 | 0.130 |
Why?
|
| Thiophenes | 1 | 2017 | 45 | 0.130 |
Why?
|
| Carcinoma, Small Cell | 2 | 2007 | 137 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2017 | 444 | 0.120 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2008 | 590 | 0.120 |
Why?
|
| Sirolimus | 1 | 2017 | 177 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Tranylcypromine | 1 | 2015 | 2 | 0.120 |
Why?
|
| Humans | 24 | 2018 | 96127 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 88 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 30 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2013 | 1829 | 0.100 |
Why?
|
| Signal Transduction | 5 | 2009 | 3586 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 611 | 0.100 |
Why?
|
| Mutation | 7 | 2011 | 4374 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2015 | 1157 | 0.100 |
Why?
|
| Neuraminidase | 1 | 2013 | 47 | 0.100 |
Why?
|
| Smad7 Protein | 1 | 2012 | 8 | 0.100 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2012 | 16 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2012 | 21 | 0.100 |
Why?
|
| Milk, Human | 1 | 2013 | 51 | 0.100 |
Why?
|
| Cell Movement | 2 | 2007 | 820 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2009 | 212 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 217 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 180 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2013 | 798 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 385 | 0.080 |
Why?
|
| Models, Biological | 1 | 2017 | 1815 | 0.080 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 85 | 0.080 |
Why?
|
| Colon | 1 | 2012 | 541 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 22 | 0.070 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2008 | 19 | 0.070 |
Why?
|
| Macrophages | 1 | 2012 | 626 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 898 | 0.070 |
Why?
|
| Vulva | 1 | 2008 | 23 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 554 | 0.070 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 16 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 84 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 297 | 0.070 |
Why?
|
| Blood Cell Count | 2 | 2018 | 79 | 0.070 |
Why?
|
| Spindle Apparatus | 2 | 2004 | 66 | 0.070 |
Why?
|
| Cell Survival | 2 | 2007 | 1032 | 0.070 |
Why?
|
| Mitosis | 2 | 2004 | 159 | 0.070 |
Why?
|
| Thiocarbamates | 1 | 2007 | 6 | 0.070 |
Why?
|
| Muridae | 1 | 2007 | 8 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1763 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 3041 | 0.070 |
Why?
|
| Sulfones | 1 | 2007 | 46 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2008 | 1351 | 0.070 |
Why?
|
| Proline | 1 | 2007 | 56 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 750 | 0.060 |
Why?
|
| Tyrosine | 1 | 2007 | 132 | 0.060 |
Why?
|
| Cell Nucleus | 4 | 2013 | 623 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 111 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 227 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 209 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 165 | 0.060 |
Why?
|
| Sodium Selenite | 1 | 2005 | 2 | 0.060 |
Why?
|
| Diethylnitrosamine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Anemia | 2 | 2018 | 137 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 68 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 26 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 76 | 0.060 |
Why?
|
| Phenobarbital | 1 | 2005 | 34 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 116 | 0.060 |
Why?
|
| Antioxidants | 1 | 2007 | 233 | 0.060 |
Why?
|
| Base Sequence | 2 | 2007 | 2344 | 0.060 |
Why?
|
| Polyamines | 1 | 2005 | 38 | 0.060 |
Why?
|
| Cell Division | 1 | 2007 | 705 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1973 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 750 | 0.060 |
Why?
|
| Neoplasms | 2 | 2011 | 3250 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2006 | 692 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 367 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 1054 | 0.050 |
Why?
|
| Transfection | 3 | 2012 | 909 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 2059 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2004 | 151 | 0.050 |
Why?
|
| Microtubules | 1 | 2004 | 134 | 0.050 |
Why?
|
| Cisplatin | 2 | 2009 | 611 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2011 | 842 | 0.050 |
Why?
|
| Histones | 2 | 2016 | 364 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 187 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2013 | 297 | 0.050 |
Why?
|
| Melanoma | 1 | 2007 | 497 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 1105 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 380 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 1089 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 625 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1761 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2013 | 535 | 0.040 |
Why?
|
| Premature Birth | 2 | 2013 | 130 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2004 | 1276 | 0.040 |
Why?
|
| Liver | 1 | 2005 | 1238 | 0.040 |
Why?
|
| Vitamin A | 1 | 2000 | 28 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 72 | 0.040 |
Why?
|
| Drug Design | 1 | 2018 | 133 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 930 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 1798 | 0.030 |
Why?
|
| Gene Expression | 2 | 2013 | 1322 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 688 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 2422 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2009 | 535 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 305 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 2 | 2008 | 355 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 44 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 2015 | 33 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2015 | 53 | 0.030 |
Why?
|
| Hydroxyurea | 1 | 2015 | 239 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 7232 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 186 | 0.030 |
Why?
|
| Tubulin | 2 | 2004 | 61 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 295 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2013 | 35 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 22 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 49 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 18 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 26 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2013 | 50 | 0.030 |
Why?
|
| Rats | 2 | 2014 | 4154 | 0.030 |
Why?
|
| Plasmids | 2 | 2004 | 291 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2004 | 395 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 124 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 126 | 0.030 |
Why?
|
| Term Birth | 1 | 2013 | 9 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 311 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2004 | 521 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2014 | 133 | 0.020 |
Why?
|
| Papio cynocephalus | 1 | 2012 | 3 | 0.020 |
Why?
|
| Papio anubis | 1 | 2012 | 7 | 0.020 |
Why?
|
| Lactation | 1 | 2013 | 55 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 548 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 327 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 223 | 0.020 |
Why?
|
| Denaturing Gradient Gel Electrophoresis | 1 | 2012 | 1 | 0.020 |
Why?
|
| Chemokine CXCL5 | 1 | 2012 | 2 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 416 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2092 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 40 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 2092 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 33 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 618 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 727 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Aged | 2 | 2008 | 20964 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1933 | 0.020 |
Why?
|
| Gestational Age | 1 | 2012 | 343 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 85 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1645 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 703 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 527 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1267 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 257 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 288 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 2480 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1010 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 396 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 439 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 308 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 28363 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 469 | 0.020 |
Why?
|
| Female | 4 | 2018 | 50063 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 872 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 710 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 2579 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 706 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2943 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2533 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 187 | 0.020 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 22 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2007 | 14 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 766 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3363 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1268 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 326 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 701 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 3240 | 0.020 |
Why?
|
| Nicotine | 1 | 2008 | 210 | 0.020 |
Why?
|
| Stem Cells | 1 | 2008 | 394 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2009 | 513 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 1068 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 741 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2614 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 46 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 246 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 407 | 0.010 |
Why?
|
| Male | 4 | 2011 | 45870 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2005 | 309 | 0.010 |
Why?
|
| Interphase | 1 | 2004 | 37 | 0.010 |
Why?
|
| Organ Size | 1 | 2005 | 379 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 70 | 0.010 |
Why?
|
| Dynactin Complex | 1 | 2004 | 2 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 270 | 0.010 |
Why?
|
| Dyneins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Gene Library | 1 | 2004 | 134 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 108 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 460 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 181 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 116 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 5585 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1958 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 200 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 444 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 564 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 518 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1034 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5960 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 1666 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 2642 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 28718 | 0.000 |
Why?
|